Trajectories of Recovery after ACutE and cRitical illness (TRACER): a prospective observational study protocol.
Felipe González-Seguel, Louisa A Summers, Lindsey E Fresenko...
https://pubmed.ncbi.nlm.nih.gov/41263932/Actively Recruiting
Led by Esther Dupont-Versteegden · Updated on 2026-06-26
209
Participants Needed
3
Research Sites
4 weeks
Total Duration
Researchers are studying patients who survive critical illness to understand why some have trouble recovering muscle strength and physical function. The study focuses on ICU-acquired weakness ICUAW, a common problem after critical illness that leads to muscle loss and long-term disability. The goal is to examine muscle recovery patterns and the cellular mechanisms behind muscle failure up to one year after hospital admission. Participants include ICU survivors and a group of healthy controls. ICU survivors will have their muscle strength, power, fatigue, and physical function measured at hospital discharge, then again at 3, 6, and 12 months. A smaller group will have muscle biopsies and blood samples taken to investigate cellular markers. Healthy controls will have a one-time assessment for comparison. Participants will undergo repeated physical function tests and muscle assessments during the year after ICU discharge. Researchers will measure changes in physical function, muscle power, mitochondrial function, and other muscle characteristics over time. The study tracks recovery trajectories and aims to identify factors linked to sustained disability. This information will help guide future treatments to improve muscle recovery after critical illness.
CONDITIONS
Muscle Recovery After Critical Illness
K
Kirby P Mayer, PhD
D
Doug Long, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Esther Dupont-Versteegden
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At hospital discharge
Participants surviving critical illness will have muscle strength, power, fatigue, and physical function measured at hospital discharge.
1 visit (in-person)
Duration - Up to 12 months
Participants will return for repeated assessments of muscle and physical function at 3, 6, and 12 months after discharge. A subgroup will provide muscle biopsies and blood samples.
3 visits (in-person)
Duration - One-time assessment
Healthy control participants will complete a one-time assessment of muscle strength, power, physical function, and muscle tissue analysis for comparison.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Felipe González-Seguel, Louisa A Summers, Lindsey E Fresenko...
https://pubmed.ncbi.nlm.nih.gov/41263932/Esther Dupont-Versteegden
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsor